Rubicon Research Private Limited: Drug Recall

Recall #D-0659-2024 · 08/24/2024

Class III: Low Risk

Recall Details

Recall Number: D-0659-2024
Classification: Class III
Product Type: Drug
Recalling Firm: Rubicon Research Private Limited
Status: Ongoing
Date Initiated: 08/24/2024
Location: Ambarnath, India
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 3,984 bottles

Reason for Recall

Discoloration

Product Description

AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01

Distribution Pattern

Nationwide in the US

Other Recalls by Rubicon Research Private Limited

Class II: Risk 05/06/2024

Presence of Foreign Substance: metal in tablet
Class II: Risk 04/26/2024

Presence of Foreign Tablets: Pharmacist reported a tablet of baclofen in a bottle of 1000-count tramadol
Class II: Risk 12/31/2021

Complaint received of foreign matter (metal) embedded in tablet.

View all recalls by Rubicon Research Private Limited →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.